PCN4 ECONOMIC EVALUATION OF INTRAVENOUS (IV) ZOLEDRONIC ACID VS. OTHER IV BISPHOSPHONATES IN THE PREVENTION OF BONE COMPLICATIONS IN BREAST CANCER PATIENTS WITH BONE METASTASES- A UK BUDGET IMPACT ANALYSIS

May 1, 2005, 00:00 AM
10.1016/S1098-3015(10)62910-5
https://www.valueinhealthjournal.com/article/S1098-3015(10)62910-5/fulltext
Section Title :
Section Order : 345
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)62910-5&doi=10.1016/S1098-3015(10)62910-5
HEOR Topics :
Tags :
Regions :